Patrick Lécine is a senior scientist in biotechnology with a strong focus on innovation in infectious diseases and immuno-oncology. They obtained a PhD in Immunology from Aix-Marseille University, where they researched gene transcription regulation in primary T cells. Patrick completed a postdoctoral fellowship at Dana-Farber Cancer Institute, studying murine hematopoiesis, and has held various senior scientist positions, including work on TB vaccine research and HBV innate immunity. Currently, Patrick serves as a Project Head in the Large Molecule Research Platform at Sanofi, leading projects in immuno-oncology based on nanobody technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices